Skip to main content
. 2023 Feb 8;7(2):100076. doi: 10.1016/j.rpth.2023.100076

Table 1.

Patient characteristics.

Patient characteristics Reference iTTPa Septic DICa P value
Numberb - 35 30 -
Age - 55.0 (42.0 to 68.5) 70.5 (64.5 to 77.0) <.01
Sex (M/F) - 15/20 16/14 .11
ADAMTS-13 activity (%) 50 to 150 <0.5 (<0.5 to <0.5) 31.8 (20.0 to 38.9) <.01
ADAMTS-13 inhibitor (BU/mL) <0.5 3.0 (1.8 to 4.2) <0.5 (<0.5 to <0.5) <.01
Hemoglobin (g/dL) M:13.7 to 16.8 8.4 (7.1 to 9.4) 10.5 (9.5 to 12.6) <.01
F:11.6 to 14.8
White blood cell (×103/μL) 3.3 to 8.6 7.1 (4.7 to 10.0) 9.5 (5.1 to 12.9) .31
Platelet (×109/L) 158 to 348 12.0 (7.3 to 17.8) 39.0 (18.5 to 48.8) <.01
LDH (U/L) 120 to 220 888 (641 to 1438) 462 (309 to 777) <.01
Creatinine (mg/dL) M:0.65 to 1.05 0.77 (0.88 to 1.17) 2.13 (1.27 to 3.50) <.01
F:0.45 to 0.80
T-Bil (mg/dL) 0.2 to 1.1 2.7 (2.2 to 4.5) 1.9 (0.8 to 4.7) .13

ADAMTS-13, a disintegrin-like metalloproteinase with thrombospondin type 1 motifs 13; BU, Bethesda unit; DIC, disseminated intravascular coagulation; iTTP, immune-mediated thrombotic thrombocytopenic purpura; LDH, lactate dehydrogenase; T-Bil, total bilirubin.

a

Each data are described as median (first quartile to third quartile).

b

All patients were Japanese.